Events

Booking Information

Venue

Pacifico Yokohama National Convention Hall

-Yokohama, Japan

Date

9-11 Oct 2019

Industry

Biotechnology

Reference No

CMP-16778-C2C1X4

Team Australia at BioJapan 2019

About the event:

BioJapan (held alongside Regenerative Medicine Japan) is Asia’s premier partnering event for the global biotechnology industry. The event is a critical platform for industry and academic experts in the drug discovery, personalised medicine, regenerative medicine and diagnostics sectors. In 2018, BioJapan had 870+ exhibitors from 34 countries and attracted 16,000+ visitors to the conference which is regarded as the biggest international conference in this field in Asia. There were also 10,000+ business discussion held through their Online Partnering Program, which is one of the attractions of participating in BioJapan event.

Austrade will coordinate Team Australia’s presence at BioJapan 2019. In conjunction with CSIRO, MTPConnect, AusBiotech and support from the Victorian, South Australian and Western Australian state governments, the Australian Government aims to increase awareness of Australia’s Life Sciences sector, high quality research capabilities, and position Australia’s biotech expertise to Japanese and international audiences. The aim is to enhance further collaboration between Australia and Japanese life sciences and medical research communities. Our involvement is sponsored by MTPConnect, Victorian, South Australian and Western Australian state governments.

Who should participate:

Australian organisations involved in:

  • human therapeutics
  • drug development
  • clinical trials services providers and CROs
  • regenerative medicine and cell therapies
  • pharmaceuticals
  • medical research.
Austrade package:

For detailed information about this event and the participation package, please refer to the event brochure.

How to apply:

Apply to participate in this event using the register button below.

Acceptance of your application is not confirmed until you have received formal notification from Austrade. Austrade is not bound to accept any application and shall only do so at its sole discretion so as to best facilitate export and foreign direct investment.

Application deadline:

20 September 2019

Travel details:

Australian travellers should be aware of the increased threat of terrorism globally and should consult the Australian Government’s General Advice to Australian Travellers, which is available at www.smartraveller.gov.au.

All Australians travelling overseas, whether for tourism or business or for short or long stays, are encouraged to register with the Department of Foreign Affairs and Trade (DFAT) before travel. The registration information provided by you will help DFAT to find you in an emergency – whether it is a natural disaster, civil disturbance or a family emergency. It may also be used to pass other information to you, such as: new travel advisories, notice of elections and information on other matters relevant to travellers and expatriates.

Australian citizens can register online at www.orao.dfat.gov.au.

Please note:

Austrade will only work with clients that maintain appropriate business ethics, and demonstrate a commitment to legal obligations including anti-bribery laws, both in Australia and overseas markets. For further information, please visit www.austrade.gov.au/legal-issues.

For more information please contact:

Rika Sasaki
Adviser International Health
Austrade Sydney
T: +61 2 9392 2369
E: Rika.Sasaki@austrade.gov.au

Airi Sakaguchi
Business Development Manager
Austrade Tokyo
T: +81 3 5232 3952
E: Airi.Sakaguchi@austrade.gov.au

Partners: CSIRO - MTPConnect - AusBiotech  Governments - VIC - SA - WA